Cerebrovascular disease results in huge health expenditures, multiple recurring physician visits, and a great number of surgical and non-surgical treatments along with research into causes and prevention. This issue addresses therapies, early therapies, diagnoses, and prevention. Topics include: Endovascular Treatment of Acute Ischemic Stroke; Acute Treatment of Blood Pressure after Ischemic Stroke and Intracerebral Hemorrhage; Diagnostic Evaluation for Non-traumatic Intracerebral Hemorrhage; Prevention of Recurrent Stroke in Patients with Patent Foramen Ovale; Management of Asymptomatic Carotid Stenosis; Stenting or Endarterectomy for Patients with Symptomatic Carotid Stenosis; The Therapeutic Value of Laboratory Testing for Hypercoagulable States in Secondary Stroke Prevention; Diagnosis and Treatment of Carotid and Vertebral Artery Dissection; Recurrent Stroke while on Anti-platelet Therapy; Anti-platelet and Anti-coagulant Therapy after Intracerebral Hemorrhage; Diagnosis and Treatment of Isolated Central Nervous System Angiitis/Vasculitis; Statins for Aneurysmal Subarachnoid Hemorrhage; Expansion of IV-tPA eligibility beyond NINDS and ECASS III criteria; and Treatment of Unruptured Arteriovenous Malformations. William J Powers MD, renowned for his clinical work with Stroke and Research in Cerebral blood flow and metabolism, and stroke treatment and prevention, leads this issue of Neurologic Clinics, with authors renown in the field.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 8 7. Preface: Cerebrovascular Diseases: Controversies and Challenges - p. 9 8. Note on Levels of Clinical Efficacy - p. 10 9. Diagnostic Evaluation for Nontraumatic Intracerebral Hemorrhage - p. 11 10. Antiplatelet and Anticoagulant Therapy After Intracerebral Hemorrhage - p. 18 11. Management of Unbled Brain Arteriovenous Malformation Study - p. 29 12. Acute Treatment of Blood Pressure After Ischemic Stroke and Intracerebral Hemorrhage - p. 36 13. Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria - p. 48 14. Endovascular Treatment of Acute Ischemic Stroke - p. 60 15. Diagnosis and Treatment of Cervical Artery Dissection - p. 71 16. Management of Asymptomatic Carotid Stenosis - p. 82 17. Stenting or Endarterectomy for Patients with Symptomatic Carotid Stenosis - p. 89 18. Recurrent Stroke while on Antiplatelet Therapy - p. 98 19. Prevention of Recurrent Stroke in Patients with Patent Foramen Ovale - p. 107 20. The Therapeutic Value of Laboratory Testing for Hypercoagulable States in Secondary Stroke Prevention - p. 113 21. Primary Angiitis of the Central Nervous System - p. 121 22. Index - p. 128
No hay muestra disponible
No hay ficha técnica disponible
Cerebrovascular disease results in huge health expenditures, multiple recurring physician visits, and a great number of surgical and non-surgical treatments along with research into causes and prevention. This issue addresses therapies, early therapies, diagnoses, and prevention. Topics include: Endovascular Treatment of Acute Ischemic Stroke; Acute Treatment of Blood Pressure after Ischemic Stroke and Intracerebral Hemorrhage; Diagnostic Evaluation for Non-traumatic Intracerebral Hemorrhage; Prevention of Recurrent Stroke in Patients with Patent Foramen Ovale; Management of Asymptomatic Carotid Stenosis; Stenting or Endarterectomy for Patients with Symptomatic Carotid Stenosis; The Therapeutic Value of Laboratory Testing for Hypercoagulable States in Secondary Stroke Prevention; Diagnosis and Treatment of Carotid and Vertebral Artery Dissection; Recurrent Stroke while on Anti-platelet Therapy; Anti-platelet and Anti-coagulant Therapy after Intracerebral Hemorrhage; Diagnosis and Treatment of Isolated Central Nervous System Angiitis/Vasculitis; Statins for Aneurysmal Subarachnoid Hemorrhage; Expansion of IV-tPA eligibility beyond NINDS and ECASS III criteria; and Treatment of Unruptured Arteriovenous Malformations. William J Powers MD, renowned for his clinical work with Stroke and Research in Cerebral blood flow and metabolism, and stroke treatment and prevention, leads this issue of Neurologic Clinics, with authors renown in the field.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 8 7. Preface: Cerebrovascular Diseases: Controversies and Challenges - p. 9 8. Note on Levels of Clinical Efficacy - p. 10 9. Diagnostic Evaluation for Nontraumatic Intracerebral Hemorrhage - p. 11 10. Antiplatelet and Anticoagulant Therapy After Intracerebral Hemorrhage - p. 18 11. Management of Unbled Brain Arteriovenous Malformation Study - p. 29 12. Acute Treatment of Blood Pressure After Ischemic Stroke and Intracerebral Hemorrhage - p. 36 13. Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria - p. 48 14. Endovascular Treatment of Acute Ischemic Stroke - p. 60 15. Diagnosis and Treatment of Cervical Artery Dissection - p. 71 16. Management of Asymptomatic Carotid Stenosis - p. 82 17. Stenting or Endarterectomy for Patients with Symptomatic Carotid Stenosis - p. 89 18. Recurrent Stroke while on Antiplatelet Therapy - p. 98 19. Prevention of Recurrent Stroke in Patients with Patent Foramen Ovale - p. 107 20. The Therapeutic Value of Laboratory Testing for Hypercoagulable States in Secondary Stroke Prevention - p. 113 21. Primary Angiitis of the Central Nervous System - p. 121 22. Index - p. 128
No hay muestra disponible
No hay ficha técnica disponible
